Fairfax Syndication - Search Result
Ajax loader
Search results for: biotech
FXB335112
fairfax-dcx_doc70dk79jmawo16j7rk3d9.jpg
FXB335111
fairfax-dcx_doc70dk6va9uidiesqa3d9.jpg
Chris Nave, managing director Brandon Capital, whose latest medical VC fund has raised $200m from industry super funds.

Chris Nave managing director Brandon Capital.
FXB40913
Chris Nave, managing director Brandon Capital, whose...
Chris Nave managing director Brandon Capital. He runs a fund that invests in biotech and medical.
FXB40912
Chris Nave managing director Brandon Capital. He runs...
Chris Nave managing director Brandon Capital. He runs a fund that invests in biotech and medical.
FXB40911
Chris Nave managing director Brandon Capital. He runs...
Chris Nave managing director Brandon Capital. He runs a fund that invests in biotech and medical.
FXB40910
Chris Nave managing director Brandon Capital. He runs...
Chris Nave managing director Brandon Capital. He runs a fund that invests in biotech and medical.
FXB40909
Chris Nave managing director Brandon Capital. He runs...
Chris Nave managing director Brandon Capital. He runs a fund that invests in biotech and medical.
FXB40908
Chris Nave managing director Brandon Capital. He runs...
MELBOURNE, AUSTRALIA - JANUARY 16:  Neuren Pharmaceuticals Executive Chairman Richard Treagus poses for a photo on January 16, 2015 in Melbourne, Australia.
FXB6735
MELBOURNE, AUSTRALIA - JANUARY 16: Neuren Pharmaceuticals...
MELBOURNE, AUSTRALIA - JANUARY 16:  Neuren Pharmaceuticals Executive Chairman Richard Treagus poses for a photo on January 16, 2015 in Melbourne, Australia.
FXB6734
MELBOURNE, AUSTRALIA - JANUARY 16: Neuren Pharmaceuticals...
MELBOURNE, AUSTRALIA - JANUARY 16:  Neuren Pharmaceuticals Executive Chairman Richard Treagus poses for a photo on January 16, 2015 in Melbourne, Australia.
FXB6733
MELBOURNE, AUSTRALIA - JANUARY 16: Neuren Pharmaceuticals...
MELBOURNE, AUSTRALIA - JANUARY 16:  Neuren Pharmaceuticals Executive Chairman Richard Treagus poses for a photo on January 16, 2015 in Melbourne, Australia.
FXB6732
MELBOURNE, AUSTRALIA - JANUARY 16: Neuren Pharmaceuticals...
MELBOURNE, AUSTRALIA - JANUARY 16:  Neuren Pharmaceuticals Executive Chairman Richard Treagus poses for a photo on January 16, 2015 in Melbourne, Australia.
FXB6731
MELBOURNE, AUSTRALIA - JANUARY 16: Neuren Pharmaceuticals...
MELBOURNE, AUSTRALIA - JANUARY 16:  Neuren Pharmaceuticals Executive Chairman Richard Treagus poses for a photo on January 16, 2015 in Melbourne, Australia.
FXB6730
MELBOURNE, AUSTRALIA - JANUARY 16: Neuren Pharmaceuticals...
Open science: Meow-Ludo Meow Meow in the Biofoundry lab in Stanmore. The lab cost less than $3000 to set up.
FXT306853
Open science: Meow-Ludo Meow Meow in the Biofoundry...
Portrait of Biofoundry Organiser Meow-Ludo Meow Meow (formerly known as Stuart McKellar) in his lab in Stanmore in Sydney who is aiming to work on a pregnancy test that also tells you the gender of t
FXT306852
Portrait of Biofoundry Organiser Meow-Ludo Meow Meow...
Portrait of Biofoundry Organiser Meow-Ludo Meow Meow (formerly known as Stuart McKellar) in his lab in Stanmore in Sydney who is aiming to work on a pregnancy test that also tells you the gender of t
FXT306851
Portrait of Biofoundry Organiser Meow-Ludo Meow Meow...
Coming into focus . . . biotechs have matured rapidly over the past few years, attracting the attention of local and international investors.

csiro 020207 afr photo Louie Douvis
generic
FXT178918
Coming into focus . . . biotechs have matured rapidly...
sod990211.002.001.jpg
 Pic Simon O'Dwyer.  Gen News.  Pic Shows.  Prof.  Suzanne Cory concerned about the lack of Govt.  support for Biotech Industry
FXT104823
sod990211.002.001.jpg
Pic Simon O'Dwyer. Gen News....
sod990211.002.003.jpg
 Pic Simon O'Dwyer.  Gen News.  Pic Shows.  Prof.  Suzanne Cory concerned about the lack of Govt.  support for Biotech Industry
FXT104822
sod990211.002.003.jpg
Pic Simon O'Dwyer. Gen News....
Dr Peter Farrell, CEO of
FXJ76438
Dr Peter Farrell, CEO of
Generic biotech researcher on 28
FXJ126282
Generic biotech researcher on 28
Generic biotech, biotechnology, research tissue
FXJ126537
Generic biotech, biotechnology, research tissue
Bio-Medical tubes with screw-top lids,
FXJ138160
Bio-Medical tubes with screw-top lids,
Andrew Nash, new CEO at
FXJ145992
Andrew Nash, new CEO at
Generic biotech, 13 April 2004.
FXJ147943
Generic biotech, 13 April 2004.
R&D 000717 PIC MICHELE MOSSOP
FXJ150305
R&D 000717 PIC MICHELE MOSSOP
John Brumby (centre) at the
FXJ154477
John Brumby (centre) at the
A laboratory technician performs scientific
FXJ162253
A laboratory technician performs scientific
Peter Crosby, chief operating officer
FXJ162998
Peter Crosby, chief operating officer
Christian Toouli, who works in
FXJ185785
Christian Toouli, who works in
Vile being filled by a
FXJ198803
Vile being filled by a
Biotechnology stocks have been the
FXJ226533
Biotechnology stocks have been the
Testing in a laboratory, 28
FXJ239636
Testing in a laboratory, 28
PICEDITOR-AFR
FXJ239637
PICEDITOR-AFR
PICEDITOR-AFR
FXJ239638
PICEDITOR-AFR
A person looks through a
FXJ241379
A person looks through a
A yellow biological waste needle
FXJ241380
A yellow biological waste needle
Male hand lifting test tubes
FXJ243865
Male hand lifting test tubes
Coloured solutions in test tubes
FXJ243867
Coloured solutions in test tubes
Lab technician mixes solution in
FXJ243868
Lab technician mixes solution in
Male hand lifting test tubes
FXJ243869
Male hand lifting test tubes
Male hand lifting test tubes
FXJ243887
Male hand lifting test tubes
Biotech 001128 AFR photo TAMARA
FXJ251464
Biotech 001128 AFR photo TAMARA
Biotech 001128 AFR photo TAMARA
FXJ251465
Biotech 001128 AFR photo TAMARA
Biotech 001128 AFR photo TAMARA
FXJ251506
Biotech 001128 AFR photo TAMARA
Biotech 001211 AFR photo TAMARA
FXJ251622
Biotech 001211 AFR photo TAMARA
Biotech 001211 AFR photo TAMARA
FXJ251651
Biotech 001211 AFR photo TAMARA
PHOTOILLUSTRATION MICHELE MOSSOP BIOTECH GENOME
FXJ252831
PHOTOILLUSTRATION MICHELE MOSSOP BIOTECH GENOME
Photo TAMARA VONINSKI biotech biotechnology
FXJ253188
Photo TAMARA VONINSKI biotech biotechnology
Photo TAMARA VONINSKI The lab
FXJ253189
Photo TAMARA VONINSKI The lab
Photo TAMARA VONINSKI biotech biotechnology
FXJ253191
Photo TAMARA VONINSKI biotech biotechnology
Con Nikolouzakis, CEO of Exinda
FXJ257711
Con Nikolouzakis, CEO of Exinda
Richard Treagus, CEO of Acrux,
FXJ273156
Richard Treagus, CEO of Acrux,
Philippe Wolgen, CEO of Clinurel
FXJ278665
Philippe Wolgen, CEO of Clinurel
Dr Greg Collier, Chief Executive
FXJ313266
Dr Greg Collier, Chief Executive
Jackie Fairley, CEO of Starpharma,
FXJ318005
Jackie Fairley, CEO of Starpharma,
While Faulding shares were sold
FXJ342305
While Faulding shares were sold
PICEDITOR-AFRG
FXJ342310
PICEDITOR-AFRG
Sort by
Display options
Items per page
Page
of 1